medline.ch Onkologie Urologische Tumoren

	Impact of the AirSeal(Â®) insufflation system on perioperative outcomes in robotic partial nephrectomy: a comparative cohort study. J Robot Surg Asali M, Asali G, Maloshevitser M. PMID: 42108280 [PubMed - indexed for MEDLINE]
	Radiologic and Pathologic Concordance of Multiparametric MRI for Detecting Unilateral Prostate Cancer: Implications for Focal Therapy Selection. Clin Genitourin Cancer Rodríguez-Cabello MA, Méndez-Rubio S, Vázquez-Alba D, Sanz-Miguelañez JL, Pozo-Mengual B, Platas-Sancho A. PMID: 42107265 [PubMed - as supplied by publisher]
	Fusion genes in precision oncology: prostate cancer as a diagnostic case study. Expert Rev Mol Diagn Morgan RA, Hardiman G. PMID: 42106974 [PubMed - as supplied by publisher]
	A Case of Pernicious Anemia Induced by Atezolizumab in Hepatocellular Carcinoma and Renal Cell Carcinoma. Am J Case Rep Sugimoto T, Kanemori G, Kanehira H, Kitao A, Nagatani Y. PMID: 42106905 [PubMed - indexed for MEDLINE]
	Comparative Efficacy of First-Line Immune Checkpoint Inhibitor-Based Combination Therapies in Patients With Sarcomatoid Renal Cell Carcinoma: A Japanese Multicenter Cohort Study. Int J Urol Tamura K, Matsushita Y, Watanabe H, Yanagisawa T, Mori K, Morinaka H, Bekku K, Toyoda S, Nukaya T, Maenosono R, Komura K, Araki M, Fujita K, Takahara K, Azuma H, Inamoto T. PMID: 42106902 [PubMed - indexed for MEDLINE]
	Detection of bladder cancer in patients with microscopic hematuria using Oncuria-Detect: results of a prospective, multicenter international study. J Transl Med Lotan Y, Anai S, Kim H, Gin G, Akhavein A, Miyake M, Luu M, Ahdoot M, Messing E, Peers G, Chen A, Moradzadeh A, Chin AI, Liu M, Tanaka S, Tikhonekov S, Pagano I, Zheng Y, Zhang Z, Furuya H, Rosser CJ. PMID: 42106837 [PubMed - as supplied by publisher]
	Proclarix' performance in ruling out patients with no or indolent prostate cancer: evaluation in a Danish population. BMC Cancer Schiess R, Athanasiou A, Kasten MME, Hansen TF, Kissow GE, Obro LF, Madsen JS, Poulsen MH, Osther PJ, Zedan AH. PMID: 42106678 [PubMed - as supplied by publisher]
	10-yr Survival and Toxicity Outcomes of Stereotactic Body Radiotherapy for Prostate Cancer: A Nonrandomized Clinical Trial. Eur Urol Meier RM, Aghdam N, Beckman AC, Woodhouse SA, Williamson SK, Mohideen N, Dombrowski JJ, Kaplan ID. PMID: 42106276 [PubMed - as supplied by publisher]
	Advanced nanomedicines to target prostate cancer cells: emerging molecular tools and future clinical prospects. Int J Pharm Abboud O, Sohail M. PMID: 42105963 [PubMed - as supplied by publisher]
	Integrated (68)Ga-PSMA PET/MRI models improve prostate cancer diagnosis and ISUP stratification, especially in the low-PSA cohort. EJNMMI Res Dai Z, Lv Y, Ruan W, Gai Y, Lan X, Qin C. PMID: 42105178 [PubMed - as supplied by publisher]
	From Genomic Testing to Olaparib Treatment: Real-World Utilization and Outcomes in BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer. Drugs Real World Outcomes Bosch D, van der Velden KJM, Beeker A, van den Berg HP, Bergman AM, van der Doelen MJ, van den Eertwegh AJM, Hendriks MP, Kerkhofs TMA, van de Luijtgaarden ACM, Mehra N, van Moorselaar RJA, Tascilar M, Vervenne WL, Weijl NI, Uyl-de Groot CA, Mulders PFA, Kuppen MCP, van Oort IM. PMID: 42105061 [PubMed - as supplied by publisher]
	The Effect of Refined Nursing on Postoperative Recovery and Inflammatory Cytokine Levels in Patients Undergoing Radical Prostatectomy for Prostate Cancer. Arch Esp Urol Liu S, Zhai X. PMID: 42104707 [PubMed - indexed for MEDLINE]
	Risk Stratification of Suspected Clinically Localized Prostate Cancer Using Multi-Indicator Functional Differentiation: A Predictive Model With fPSA/tPSA, PHI, PCA3, and MRI. Arch Esp Urol Li L, Xu Y, Chen M. PMID: 42104706 [PubMed - indexed for MEDLINE]
	Predictors of BCG Therapy Complications in Non-Muscle-Invasive Bladder Cancer: A Clavien-Dindo-Based Study. Arch Esp Urol Turan T, Efiloglu O, Hamidzada I, Ahmadzada J, Polat S, Yildirim A. PMID: 42104704 [PubMed - indexed for MEDLINE]
	Correlation of Serum Adiponectin and Metabolic Syndrome Components With Prostate Cancer Susceptibility and Construction of a Nomogram Prediction Model. Arch Esp Urol Cheng L, Zhou X, Pan J, Xing Y, Fu J, Zhang W, Zhang Z. PMID: 42104702 [PubMed - indexed for MEDLINE]
	Genetically Predicted Gut Microbiota and Bladder Cancer Risk: A Mendelian Randomisation Analysis. Arch Esp Urol Wei F, Zhao M, Sun X, Ma H, Yin H, Shen X, Chen S. PMID: 42104697 [PubMed - indexed for MEDLINE]
	Association of Inflammatory and Nutritional Biomarkers with Pathological Response in Patients with Muscle-invasive Bladder Carcinoma Treated with Neoadjuvant Chemotherapy. Arch Esp Urol Navarro-Jiménez S, Carrión-López P, Lorenzo-Sánchez MV, Tárraga-Honrubia MA, Díaz-de-Mera-Sánchez-Migallón I, Giménez-Bachs JM, Salinas-Sánchez AS. PMID: 42104694 [PubMed - indexed for MEDLINE]
	Development of a Novel Nomogram to Predict Biochemical Failure and Prostate Cancer-Specific Mortality After Definitive Radiotherapy in Patients with Gleason Score 7 Prostate Cancer. Arch Esp Urol Elmal A, Demirhan B, Senturk E, Guler OC, Erpolat P, Onal C. PMID: 42104693 [PubMed - indexed for MEDLINE]
	Current Evidence on the Use of Cystoscopy in the Follow-up of Non-Muscle-Invasive Bladder Cancer: Are We Overusing It? Systematic Review of the Literature. Arch Esp Urol Baudet León J, Caño Velasco J, Polanco Pujol L, Artero Fullana S, Pastor Rodenas B, Subiela Henriquez JD, García Martín LA, Hernández Fernández C, Bielsa Carrillo A. PMID: 42104689 [PubMed - indexed for MEDLINE]
	Risk Assessment of Non-Urinary Tract Recurrence After Radical Nephroureterectomy Based on CheckMate 274 Trial Eligibility: A Multicenter Retrospective Study. Int J Urol Shindo T, Ueki Y, Muranaka I, Kobayashi G, Miyamoto S, Kunishima Y, Sato S, Okada M, Kato S, Kato R, Adachi H, Matsukawa M, Takayanagi A, Shibamori K, Wanifuchi A, Kyoda Y, Hashimoto K, Kobayashi K, Tanaka T, Masumori N. PMID: 42104674 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 178123

Seite 1 von 8907

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung